AKT1 and hepatocellular carcinoma: The PI3K/AKT and MAPK pathways are frequently activated in HCC and are known to modulate sorafenib resistance and the miRNAs that regulate these pathways, thereby apoptosis and autophagy, and also modulate sorafenib resistance [113,114,115,116].